IV Stem Cell Therapy: Systemic Benefits, Safety, and Who Qualifies
Intravenous (IV) stem cell therapy is an emerging regenerative approach designed to influence the body’s healing environment at a systemic level. At Cellular Regeneration Clinic (CRC), we use donor‑derived (allogeneic) umbilical‑cord mesenchymal stem cells (MSCs) and exosomes processed in our COFEPRIS‑licensed lab—no patient cell harvest is required. This guide explains how IV therapy is performed, who may be considered, and how we prioritize safety.
What Is IV Stem Cell Therapy?
IV stem cell therapy involves a controlled infusion of allogeneic UC‑MSCs and/or exosomes into the bloodstream. Cells and vesicles circulate systemically, interacting with immune cells and tissues via paracrine (cell‑to‑cell signaling) mechanisms. Our goal is to help modulate inflammation, support vascular health, and promote a pro‑healing environment alongside your existing medical care.
Potential Systemic Benefits
- Immunomodulation: MSC signaling can help balance overactive or dysregulated inflammatory responses.
- Endothelial support: Paracrine factors may aid microcirculation and tissue perfusion.
- Tissue recovery: Exosomes deliver growth factors and micro‑RNAs that may support cellular repair pathways.
- Whole‑body approach: Suitable when issues are diffuse or multi‑system rather than localized to a single joint or structure.
Important: Responses vary. IV therapy is not a cure for chronic disease and should be considered an adjunct to, not a replacement for, standard medical care.
Who May Qualify?
CRC considers IV therapy for adults after a specialist evaluation. Candidates typically include those seeking systemic support for:
- Chronic, low‑grade inflammatory states impacting energy, recovery, or comfort
- Autoimmune or metabolic conditions under the care of a treating physician
- Adjunct recovery support after illness or injury when appropriate
- Wellness and healthy aging goals within a supervised program
Not typically candidates: active infection, uncontrolled hypertension or diabetes, pregnancy/breastfeeding, history of severe allergic reactions to biologic infusions, active cancer or recent chemotherapy, or inability to pause certain anticoagulants when medically indicated. Your CRC clinician will review your case in detail.
Safety First: How CRC Protects Patients
- COFEPRIS‑licensed lab: Donor screening, sterility, and viability testing; each lot includes a certificate of purity and cell count.
- No embryonic cells: We use umbilical‑cord‑derived MSCs and exosomes only.
- Medical oversight: Pre‑infusion vitals and review of medications; continuous observation during the procedure.
- Expected effects: Temporary fatigue, flushing, mild headache, or low‑grade fever can occur; serious reactions are uncommon but reviewed during consent.
What to Expect on Treatment Day
- Consultation & planning — review goals, history, labs, and current therapies with a CRC clinician.
- Cell preparation — your allogeneic MSCs/exosomes are selected, thawed, and prepared; documentation of purity and viability is reviewed with you.
- IV infusion — a peripheral IV is placed; infusion typically takes 30–60 minutes under clinical monitoring.
- Observation & discharge — short monitoring period followed by detailed post‑care and follow‑up schedule.
Before & After Your Infusion
- Before: Hydrate well, eat a light meal, and follow any medication guidance provided by your clinician.
- After (first 24–48 hours): Continue hydration, limit alcohol, avoid strenuous exercise if you feel fatigued, and note any symptoms to discuss at follow‑up.
- Follow‑ups: Typically at 1, 3, and 6 months to review progress and tailor adjunct therapies (nutrition, PT, sleep, stress management).
IV vs. Other Delivery Routes
| Route | Best Use Case | Notes |
|---|---|---|
| IV MSCs / Exosomes | Systemic or multi‑system support | Non‑surgical, full‑body signaling; responses vary by condition |
| Local injections (e.g., joints, spine) | Well‑localized pain generators | Targets a specific structure; often paired with rehab |
| Intrathecal (IT) | Select neurologic indications | Image‑guided lumbar delivery; candidacy is case‑by‑case |
Why Choose CRC for IV Stem Cell Therapy
- COFEPRIS‑licensed in‑house lab and documented quality control.
- Experienced multidisciplinary team coordinating with your treating physicians.
- Personalized protocols and structured follow‑ups—no one‑size‑fits‑all plans.
- Convenient Tijuana location, 20 minutes from San Diego Airport.
Meet the Team
Get to know the specialists who evaluate candidacy, supervise infusions, and design your recovery plan.
Inside Our Clinic
Tour our modern infusion rooms and patient amenities designed for comfort, safety, and efficiency.
Our In‑House, COFEPRIS‑Licensed Lab
Learn how donor‑derived UC‑MSCs and exosomes are screened, prepared, and documented prior to your infusion—no patient harvest required.
Frequently Asked Questions
How soon might I notice changes?
Some people report early shifts in energy or recovery within weeks, while others notice gradual changes over 1–3 months. Outcomes vary by health status and goals.
How many IV sessions will I need?
Plans are individualized. Many patients begin with a single infusion and reassess at follow‑up; periodic boosters may be discussed with your clinician.
Can I combine IV therapy with local injections?
Yes, in selected cases. Your CRC specialist may combine strategies (e.g., IV + targeted joint or spine therapy) based on your priorities and imaging.
Is IV stem cell therapy safe with my current medications?
We review your medication list carefully. Never change prescribed drugs without your treating physician’s guidance—we coordinate care for safety.
This article is educational and not a medical diagnosis or treatment plan. Please contact a CRC specialist for personalized guidance—con gusto consultaremos con un especialista de CRC.
